{
    "root": "619915d1-ea93-464c-beda-732dd419542e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sodium Fluoride Chewable",
    "value": "20240529",
    "ingredients": [
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MALIC ACID",
            "code": "817L1N4CKP"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "XYLITOL",
            "code": "VCQ006KQ1E"
        },
        {
            "name": "SODIUM FLUORIDE",
            "code": "8ZYQ1474W7"
        }
    ],
    "indications": "daily self-applied systemic dental caries preventive pediatric patients . established ingestion fluoridated drinking water ( 1 ppm f¯ ) period tooth development results significant decrease incidence dental caries . sodium fluoride chewable tablets developed provide systemic fluoride supplement pediatric patients age 3 years age 16 years older living areas drinking water fluoride contents exceed 0.6 ppm f¯ .",
    "contraindications": "( table ) dissolve mouth chew swallowing , preferably bedtime brushing teeth . schedule determine .",
    "warningsAndPrecautions": "tablet contains 0.5 mg fluoride 1.1 mg sodium fluoride . white off-white , orange flavor , round-shaped chewable tablet . debossed `` m161 `` one side . ndc 63629-1132-1 ( 120 count ) . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "fluoride 1.0 mg tablets contraindicated fluoride content drinking water > 0.3 ppm f¯ administered pediatric patients 6 years . fluoride 0.5 mg tablets contraindicated fluoride content drinking water 0.6 ppm f¯ administered pediatric patients age 6 fluoride content drinking water 0.3 ppm f¯ pediatric patients age 3 years . fluoride 0.25 mg tablets contraindicated fluoride content drinking water 0.6 ppm f¯ administered pediatric patients age 3 years fluoride content drinking water 0.3 ppm f¯ . administer sodium fluoride chewable tablets ( strength ) pediatric patients age 3 years . sodium fluoride chewable tablets ( strength ) indicated adults .",
    "indications_original": "For once daily self-applied systemic use as a dental caries preventive in pediatric patients. It has been established that ingestion of fluoridated drinking water (1 ppm F¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. Sodium Fluoride Chewable Tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm F¯.",
    "contraindications_original": "(for dosage see table)\n                  Dissolve in the mouth or chew before swallowing, preferably at bedtime after brushing teeth. See schedule below to determine dosage.",
    "warningsAndPrecautions_original": "Each tablet contains 0.5 mg Fluoride from 1.1 mg Sodium Fluoride. White to off-white, orange flavor, round-shaped chewable tablet. Debossed with \"M161\" on one side.\n                  NDC 63629-1132-1 (120 count).\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Fluoride 1.0 mg Tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm F¯ and should not be administered to pediatric patients under 6 years. Fluoride 0.5 mg Tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm F¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm F¯ or more or to pediatric patients under age 3 years. Fluoride 0.25 mg Tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm F¯ and should not be administered to pediatric patients under age 3 years when the fluoride content of drinking water is 0.3 ppm F¯ or more. Do not administer Sodium Fluoride Chewable Tablets (any strength) to pediatric patients under age 3 years. Sodium Fluoride Chewable Tablets (any strength) are not indicated for use in adults."
}